SCHEMBL7127555

SCHEMBL7127555

CCCCCCC(C)N(c1ccc(N(C)C)cc1)C(C)CCCCCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4A O75164 4/20 0.44
KDM2A Q9Y2K7 4/20 0.44
HDAC11 Q96DB2 1/20 0.42
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 2/20 0.41
ALOX15 P16050 1/20 0.41
CYP3A4 P08684 2/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 2/20 0.38
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
CNR2 P34972 1/20 0.37
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2991745 0.84 ALDH1A1 (0.42) ALDH1A1TSHRALOX15CYP3A4MAPK1
SCHEMBL5223757 0.83 CSNK1E (0.42) ALDH1A1CNR2NPC1RAB9A
SCHEMBL5226408 0.83 CSNK1E (0.42) ALDH1A1CNR2NPC1RAB9A
SCHEMBL11073253 0.82 KDM4A (0.39) KDM4AKDM2AHDAC11ALDH1A1HSD17B10
SCHEMBL5228284 0.81 CSNK1E (0.40) ALDH1A1CNR2NPC1RAB9A
SCHEMBL5625535 0.81 OPRM1 (0.37) KDM4AKDM2AHDAC11ALDH1A1LMNA
SCHEMBL12304299 0.80 BDKRB2 (0.34) ALDH1A1HSD17B10CYP3A4LMNAMAPT
SCHEMBL21730035 0.80 GAA (0.43) KDM4AKDM2AHDAC11ALDH1A1HSD17B10
SCHEMBL5563296 0.78 ALDH1A1 (0.50) HDAC11ALDH1A1HSD17B10TSHRALOX15
SCHEMBL3897372 0.78 SIGMAR1 (0.44) KDM4AKDM2AHDAC11ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6541549-B2 Oxidation resistance CROMPTON CORPORATION 2003-04-01 US disclosed
US-20010053805-A1 NON-XENOESTROGENIC STABILIZERS FOR ORGANIC MATERIALS ADDIVANT USA, LLC 2001-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010053805-A1 NON-XENOESTROGENIC STABILIZERS FOR ORGANIC MATERIALS YWHAZ, ALPL, PAX2 KDM4A 756/4885KDM2A 795/4885HDAC11 4283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.